Pediatric insomnia: new insights in clinical assessment and treatment options

Oliviero Bruni1, Marco Angriman

  • 1Department of Developmental and Social Psychology, Sapienza University Via dei Marsi 78 - 00185 Rome, Italy.

Insights

Pediatric sleep disorders impact child development and family well-being. A medical approach assessing contributing factors, behaviors, and sleep schedules is crucial for effective diagnosis and treatment of childhood insomnia.

Area of Science:

  • Pediatric Sleep Medicine
  • Child Psychology
  • Developmental Pediatrics

Background:

  • Sleep disorders in children significantly affect quality of life and are linked to developmental issues, obesity, and behavioral problems.
  • Chronic sleep deprivation in childhood can lead to adverse developmental outcomes and behavioral disturbances.
  • Routine health assessments should include sleep-related questions to identify potential sleep disorders early.

Purpose of the Study:

  • To outline a medical approach for assessing pediatric insomnia, considering primary and secondary factors.
  • To emphasize the importance of examining sleep/wake schedules, sleep behaviors, and daytime consequences.
  • To introduce a novel classification for pediatric insomnia and suggest tailored treatment strategies.

Main Methods:

  • Clinical assessment focusing on sleep/wake patterns, nocturnal behaviors, and daytime impacts.
  • Evaluation of the sleeping environment and bedtime routines to identify behavioral influences.
  • Utilizing actigraphy for objective sleep parameter estimation when polysomnography is not routinely indicated.

Main Results:

  • A comprehensive medical assessment is vital for understanding pediatric insomnia.
  • Actigraphy offers a practical method for objective sleep assessment in children.
  • A new classification integrating genetic and clinical aspects of pediatric insomnia is proposed.

Conclusions:

  • Effective management of pediatric sleep disorders requires a thorough medical evaluation and tailored interventions.
  • Sleep hygiene, behavioral strategies, and pharmacological treatments are key components of pediatric insomnia management.
  • A new classification system aims to improve the diagnosis and treatment of childhood insomnia.

Related Concept Videos

Management of Insomnia01:19

Management of Insomnia

The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
778
Insomnia01:27

Insomnia

Insomnia is a prevalent sleep disorder characterized by difficulty falling asleep, frequent awakenings during the night, and waking up too early without being able to return to sleep. People with insomnia often experience these disruptions at least three nights a week for at least one month. Chronic insomnia, which lasts for at least three months, can lead to increased anxiety, which in turn can worsen sleep difficulties, creating a cycle of sleeplessness and stress.
Multiple factors contribute...
576
Sedatives and Hypnotics Drugs: Miscellaneous Agents01:17

Sedatives and Hypnotics Drugs: Miscellaneous Agents

Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
831
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
372
Nightmares and Night Terrors01:18

Nightmares and Night Terrors

Nightmares and night terrors represent two distinct types of sleep disturbances that differ in timing, characteristics, and the sleeper's recall of the event. Nightmares are vivid, disturbing dreams that usually awaken the sleeper from REM sleep, a stage of sleep where brain activity is high, and dreams are most frequent. Upon awakening, individuals often have detailed recollections of their nightmares, which can include themes of threats to survival, security, or self-esteem.
Nightmares...
780
Sedatives and Hypnotics: Overview01:23

Sedatives and Hypnotics: Overview

Sedatives are drugs that alleviate anxiety, while hypnotics induce sleep. Both classes of medication suppress neuronal activity, leading to a calming effect for sedatives and facilitating sleep for hypnotics.
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
2.0K